Alhambra Investment Partners LLC Abbott Laboratories Transaction History

Alhambra Investment Partners LLC

$189 Million
Q3 2024

A detailed history of Alhambra Investment Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 4,156 shares of ABT stock, worth $494,356. This represents 0.25% of its overall portfolio holdings.

Number of Shares

4,156

Previous 4,156 -0.0%

Holding current value

$494,356

Previous $431,000 9.74%

% of portfolio

0.25%

Previous 0.24%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $20,347 - $22,712	-202 Reduced 4.64%	4,156 $431,000
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $16,647 - $18,385	-152 Reduced 3.37%	4,358 $495,000
Q4 2023 Jan 17, 2024	SELL	$90.19 - $110.4 $4,509 - $5,520	-50 Reduced 1.1%	4,510 $496,000
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $1,840 - $2,166	19 Added 0.42%	4,560 $461,000
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $950 - $1,115	-10 Reduced 0.22%	4,541 $0
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $4,838 - $5,601	-50 Reduced 1.09%	4,551 $440,000
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $3,062 - $3,701	-30 Reduced 0.65%	4,601 $500,000
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $10,147 - $12,374	-89 Reduced 1.89%	4,631 $548,000
Q4 2021 Jan 21, 2022	SELL	$115.53 - $141.46 $48,522 - $59,413	-420 Reduced 8.17%	4,720 $664,000
Q1 2021 Apr 16, 2021	SELL	$108.84 - $128.23 $47,671 - $56,164	-438 Reduced 7.85%	5,140 $616,000
Q3 2020 Nov 17, 2020	SELL	$91.64 - $111.29 $8,430 - $10,238	-92 Reduced 1.62%	5,578 $607,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $11,485 - $14,700	150 Added 2.72%	5,670 $518,000
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $433,375 - $482,448	5,520 New	5,520 $479,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.

Account

Alhambra Investment Partners LLC Abbott Laboratories Transaction History